Blog Archive

Αλέξανδρος Γ. Σφακιανάκης

Tuesday, July 27, 2021

Aesthetic forehead reduction in female patients: Surgical details and analysis of outcome

xlomafota13 shared this article with you from Inoreader

J Plast Reconstr Aesthet Surg. 2021 Jun 18:S1748-6815(21)00335-1. doi: 10.1016/j.bjps.2021.06.002. Online ahead of print.

ABSTRACT

INTRODUCTION: Primary aesthetic hairline lowering, also known as forehead reduction, is a relatively unexplored procedure, and the perceived satisfaction with outcome has not been previously discussed in scientific literature. The objectives of this study were to review the surgical technique and to analyze outcome assessing objective reduction, improvement of facial balance, patient satisfaction, and complications.

PATIENTS AND METHODS: This was a prospective cohort study of patients seeking aesthetic forehead reduction since 2010. Inclusion criteria were as follows: women with a high but stable hairline. We excluded smokers, those seeking combined surgery, and those who had history of scalp surgery or hair loss. All patients were operated following the same protocol. Forehead reduction was measured comparing the pre- and postoperative distance from the glabella to the trichion. Improvement in facial balance was assessed comparing the pre- and postoperative quotient between the upper and middle thirds of the face. The forehead FACE-Q tool and the Vancouver Scar Scale were used to assess patient satisfaction. All complications were registered with a minimum follow-up of 6 months.

RESULTS: Twenty-six women aged 16 to 56 years were included. The average reduction was 2.03 cm. The facial balance quotient improved from 1:1.44 preoperatively to 1:1.05 postoperatively (p < 0.01). Both the forehead FACE-Q and the Vancouver Scar Scale showed significantly positive results. Complications included transient scalp numbness in 23 subjects, small areas of scar widening in 3 patients, and minor seroma in 1 patient.

CONCLUSION: With meticulous execution, aesthetic forehead reduction in female patients is effective and safe, resulting in high patient satisfaction. The FACE-Q is o wned by the Memorial Sloan Kettering Cancer Center (MSKCC) and was used with permission for this research.

PMID:34305024 | DOI:10.1016/j.bjps.2021.06.002

View on the web

No comments:

Post a Comment